Patents by Inventor Bruce Pratt

Bruce Pratt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12342031
    Abstract: A system for out of band control for legacy set top boxes in which an out-of-band (OOB) downstream signal containing control information for consumer premises equipment is transmitted to an end-of-line device, which converts it to an upstream OOB signal, then sends the upstream OOB signal in an upstream direction.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: June 24, 2025
    Assignee: ARRIS Enterprises LLC
    Inventors: Michael R. Morisseau, Clarke V. Greene, David Bowler, Bruce Pratt
  • Publication number: 20230137077
    Abstract: A system for out of band control for legacy set top boxes.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 4, 2023
    Applicant: ARRIS Enterprises LLC
    Inventors: Michael R. MORISSEAU, Clarke V. GREENE, David BOWLER, Bruce PRATT
  • Patent number: 5219576
    Abstract: Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm.sup.3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.
    Type: Grant
    Filed: December 3, 1991
    Date of Patent: June 15, 1993
    Assignee: Collagen Corporation
    Inventors: George H. Chu, Yasushi Ogawa, John M. McPherson, George Ksander, Bruce Pratt, Diana Hendricks, Hugh McMullin
  • Patent number: 5110604
    Abstract: Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm.sup.3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: May 5, 1992
    Assignee: Collagen Corporation
    Inventors: George H. Chu, Yasushi Ogawa, John M. McPherson, George Ksander, Bruce Pratt, Diana Hendricks, Hugh McMullin
  • Patent number: 5024841
    Abstract: Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm.sup.3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.
    Type: Grant
    Filed: June 30, 1988
    Date of Patent: June 18, 1991
    Assignee: Collagen Corporation
    Inventors: George H. Chu, Yasushi Ogawa, John M. McPherson, George Ksander, Bruce Pratt, Diana Hendricks, Hugh McMullin